Nucleic Acid Amplification Testing (NAAT) Molecular Analyzers
ID: HT9408-25-NAATType: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYSAN ANTONIO, TX, 78230, USA

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

PSC

ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE (6632)

Original Source

https://sam.gov/opp/d75cf7635a394e30a96ce4b331bc3500/view
Timeline
    Description

    The Department of Defense, through the Defense Health Agency (DHA), is conducting a Request for Information (RFI) to identify potential contractors capable of providing Nucleic Acid Amplification Testing (NAAT) Molecular Analyzers for Naval Hospital Pensacola, Florida. This procurement aims to gather information on qualified offerors who can meet the requirements under the NAICS code 334516, which pertains to Analytical Laboratory Instrument Manufacturing. NAAT Molecular Analyzers are critical for medical laboratory use, facilitating accurate and timely testing in healthcare settings. Interested parties are encouraged to submit their company information and relevant qualifications by March 17, 2025, with no extensions permitted. For inquiries, contact Sylas Younger at sylas.a.younger.civ@health.mil or Marcus Mattingly at marcus.h.mattingly.civ@health.mil.

    Files
    Title
    Posted
    RFI Sources Sought NAAT - Molecular Analyzers.docx
    The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division – South (HCD-S), is conducting a Request for Information (RFI) to identify potential contractors capable of providing Nucleic Acid Amplification Testing (NAAT) Molecular Analyzers for Naval Hospital Pensacola, FL. The anticipated NAICS code for this acquisition is 334516, Analytical Laboratory Instrument Manufacturing. The government is exploring whether to set aside this requirement for small businesses or pursue full and open competition, based on responses received. This RFI is purely for market research purposes and not a solicitation for offers, meaning no awards will be made based on the responses. Interested parties should provide company information and relevant qualifications by March 17, 2025, with no extensions allowed. The RFI encourages small businesses to detail their qualifications and certifications relative to the NAICS code. Correspondence regarding this RFI should be directed to the specified points of contact within DHACA, ensuring compliance with established privacy regulations. Ultimately, the goal is to collect data on potential qualified offerors for NAAT Molecular Analyzers.
    Lifecycle
    Title
    Type
    Nucleic Acid Amplification Testing (NAAT) Molecular Analyzers
    Currently viewing
    Sources Sought
    Similar Opportunities
    Cost per Test Equipment, Becton BD BACTEC FX and Bruker MALDI Biotyper for the Infectious Disease Laboratory at Walter Reed National Military Medical Center
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking sources for the procurement of cost per test equipment, specifically the Becton BD BACTEC FX and Bruker MALDI Biotyper, for the Infectious Disease Laboratory at Walter Reed National Military Medical Center in Bethesda, Maryland. This procurement aims to enhance laboratory capabilities in diagnosing infectious diseases, which is critical for patient care and public health. Interested vendors should note that the opportunity is categorized under the NAICS code 334516, focusing on Analytical Laboratory Instrument Manufacturing, and the PSC code 6545, which pertains to replenishable field medical sets, kits, and outfits. For further inquiries, potential bidders can contact Kendall Spann at kendall.j.spann.civ@health.mil.
    Request for Information (RFI) for Device and Maintenance Services for medical point-of-care molecular disease analyzer.
    Buyer not available
    The Department of Homeland Security, specifically the U.S. Coast Guard (USCG), is issuing a Request for Information (RFI) to explore the market for medical point-of-care molecular disease analyzers, with the intent to replace its aging Cepheid GeneXpert systems. The USCG aims to procure approximately 55 new devices that can test for multiple diseases, including SARS-CoV-2, Influenza A and B, and various bacterial infections, emphasizing the need for FDA approval, high specificity and sensitivity, rapid turnaround times within 60 minutes, and compatibility with electronic health records. This initiative is crucial for enhancing the USCG's medical capabilities and ensuring timely disease detection among personnel. Interested vendors are encouraged to submit their responses by March 25, 2025, and can direct inquiries to Jamison Harned at jamison.w.harned@uscg.mil or by phone at 571-613-5151.
    Discrete Analyzer
    Buyer not available
    The Department of Defense, specifically the Army Research Laboratory, is conducting a Sources Sought Notice to identify potential vendors for an automated discrete analyzer designed for enzyme assays. The analyzer must be capable of automating the analysis of various samples, conducting multiple assay types, and maintaining precise environmental conditions, while also supporting both commercially available and user-prepared reagents. This equipment is crucial for high-throughput testing in laboratory settings, ensuring efficiency and accuracy in analytical processes. Interested parties are encouraged to respond within five days, detailing their capabilities and experience, with the expectation of contract performance at the Army Research Laboratory Center in Maryland and delivery anticipated within 6-8 weeks post-award. For inquiries, contact David Erb at david.j.erb4.civ@army.mil or call 520-672-9596.
    Lab Chemistry Analyzer and Cost-Per-Test Agreement for Robins Air Force Base
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for a Lab Chemistry Analyzer and a Cost-Per-Test Agreement specifically for Robins Air Force Base located in Warner Robins, Georgia. This procurement aims to acquire analytical laboratory instruments that are crucial for chemical analysis, ensuring efficient and accurate testing capabilities within military healthcare facilities. Interested vendors should note that the primary contact for this opportunity is Brittany Belsches, who can be reached at brittany.n.belsches.civ@health.mil, while secondary inquiries can be directed to Lenore Y. Paseda at lenore.y.paseda.civ@health.mil. Further details regarding the timeline and funding specifics will be provided in the forthcoming solicitation.
    6640--FY25 Q3 Micro Molecular Testing (VA-25-00029953)
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of Micro Molecular Testing supplies for the West Palm Beach VA Hospital, under Solicitation No. 36C24825Q0395. The procurement includes various laboratory items and equipment, such as testing kits and the leasing of laboratory instruments, with a requirement for vendors to be Authorized Distributors and provide proof of their status. This initiative is part of the VA's commitment to enhancing its laboratory capabilities to effectively serve veterans. Interested vendors must submit their quotations via email by March 12, 2025, at 2:00 PM Eastern Time, and are encouraged to stay updated on any changes to the solicitation through the Beta-Sam website. For further inquiries, vendors can contact Contract Officer David Henry at David.Henry3@va.gov or by phone at 561-631-3352.
    Brand Name or Equivalent of Bio-Rad Evolis and Geenius serological automated analyzers with UPS backup systems for the Walter Reed Army Institute of Research (WRAIR)
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is seeking sources for the procurement of Bio-Rad Evolis and Geenius serological automated analyzers, along with uninterrupted power supply (UPS) backup systems, for the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, Maryland. The requirement includes high-volume HIV testing and confirmation capabilities, with specifications for independent processing systems, automated sample integrity detection, and compatibility with existing laboratory systems, all while adhering to FDA regulations for HIV screening. This initiative is crucial for enhancing infectious disease management among U.S. service members, particularly concerning HIV and hepatitis C. Interested vendors should contact Brenda Mena at brenda.i.mena.civ@health.mil or Sharew Hailu at sharew.hailu.civ@health.mil for further details, as the contract is expected to span from September 30, 2025, to September 29, 2030.
    Notice of Intent- Sole Source - Bench Mark Ultra, Bench Mark Ultra Plus, and VENTANA HE 600
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), has issued a Notice of Intent for a sole source procurement of Bench Mark Ultra, Bench Mark Ultra Plus, and VENTANA HE 600 instruments. This procurement aims to acquire analytical laboratory instruments essential for medical and surgical applications, specifically within the healthcare sector of the military. These instruments play a critical role in diagnostic processes and patient care, ensuring that healthcare providers have access to reliable and advanced technology. Interested vendors can reach out to Claudia Febres Mormontoy at claudia.a.febresmormontoy.ctr@health.mil or call 703-275-6342 for further details regarding this opportunity.
    Q301-- Five (5) Full-Time Equivalent Certified Medical Technologists
    Buyer not available
    The Department of Veterans Affairs is seeking to procure the services of five full-time certified Medical Technologists to support the Public Health National Program Office. These professionals will be responsible for performing high-complexity molecular laboratory testing and laboratory information management services, which are critical for the nation's biodefense strategy and public health preparedness, particularly in diagnosing emerging pathogens and high-consequence infections. Interested vendors must respond with their company details and capabilities by March 13, 2025, with a preference for submissions from service-disabled veteran-owned and veteran-owned small businesses. For further inquiries, potential respondents can contact Contracting Officer Larry Facio at Larry.Facio@va.gov or by phone at 916-923-4553.
    6550--Lab Testing Services - (HIV/HCV/HPV/On)
    Buyer not available
    The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
    Next Sequencing 2000 System
    Buyer not available
    The Department of Defense, through the Naval Medical Research Center, is soliciting proposals for the procurement of the NextSeq 2000 Sequencing System, specifically targeting women-owned small businesses (WOSB). This solicitation outlines the requirements for delivery, acceptance, and compliance with federal regulations, emphasizing firm fixed pricing and the need for unique identifiers for items valued at $5,000 or more. The NextSeq 2000 Sequencing System is crucial for advanced genomic research and analysis, supporting the Department's mission in medical research and development. Interested vendors should contact Deborah M. Sharpe at deborah.m.sharpe2.civ@health.mil or Stephanie Gray at Stephanie.Gray@med.navy.mil for further details, with submissions expected to adhere to the outlined guidelines and deadlines.